029HO14062 GILLESPY

Registration Name DE-SU GILLESPY-ET
Registration Number HOUSA000063449626
Primary NAAB Code 029HO14062
Secondary Code(s) 629HO14026, 529HO14062, 530HO14062, 531HO14062, 532HO14062, 533HO14062
Status Inactive
Controller Name ABS Global (29)
Date of Birth 6/29/2007
aAa 312
DMS 234,123
GFI 9.2%
Genetic Codes * BY TV TL TD
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HCD-T
Beta Casein A1A2
Kappa Casein AA
Beta Lactoglobulin AA
INDEXES
NM$ -169, 93% R CM$ -204
NM Percentile 13% FM$ -84
GTPI 2333 GM$ -236
PRODUCTION TRAITS
31013 Dtrs 7498 herds 17 % US 99% R
Milk 1168 Fat, % -11 , -0.22%
SCS 2.85, 99% R Protein, % 8 , -0.11%
Feed Saved -96 , 62% R Milking Speed 6.23 , 82% R
Health & Fertility
Productive Life -1.9      99% R Mastitis -0.7      97% R
Heifer Livability 0.6       87% R Metritis -2.8      91% R
Livability -1.1      96% R D. Abom 0.4      96% R
DPR -4.0      99% R Ketosis -1.2      92% R
FSC -11.4      99% R R. Placenta -0.6      93% R
HCR -1.0      97% R Milk Fever 0.0      82% R
CCR -4.2      99% R
SCR -        -
DIA -0.7      62% R
RSP 0.1      76% R
Calving Traits
Sire CE 2.0      99% R 35733 Obs
Daughter CE 2.4      98% R 6190 Obs, 19115 Dtrs
Sire SB 4.0      98% R 36496 Obs
Daughter SB 5.5      98% R 5667 Obs, Dtrs
Gestation Length 2.2      99% R 1059 Obs, 10888 Dtrs
Early First Calving -1.6      99% R 1024 Obs, 4774 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
16548 Dtrs 4580 herds 98% R
PTA Type 0.55 UDC 0.10
HCC 1.08 BWC -0.22
FLC 0.72
Linear Traits
Stature 0.68
Tall
Strength 0.07
Strong
Body Depth 0.78
Deep
Dairy Form 1.45
Open
Rump Angle 1.73
Sloped
Thurl Width 1.16
Sloped
Rear Legs-Side View 1.16
Wide
Rear Legs-Rear View 0.59
Straight
Foot Angle 0.72
Steep
Feet & Legs Score 0.91
High
F.U. Attachment 1.06
Curved
Rear Udder Height 0.60
High
Rear Udder Width 0.32
Wide
Udder Cleft 1.05
Strong
Udder Depth 0.59
Straight
Front Teat Placement 1.30
Close
Rear Teat Placement 1.73
Close
Teat Length 0.31
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO